Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
OBJECTIVES: The purpose of this study was to validate the lower end of the putative therapeutic range of serum tacrine concentrations of 7-20 ng ml(-1) in the treatment of Alzheimer's disease. METHODS: The relationship between dose, steady-state serum tacrine concentrations and change in MMSE s...
Հիմնական հեղինակներ: | Roberts, C, Ford, J, Truman, C, Scott, M, Mäkelä, P, Wilcock, G |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
1998
|
Նմանատիպ նյութեր
-
Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
: Forsyth, DR, և այլն
Հրապարակվել է: (1989) -
Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
: Ford, J, և այլն
Հրապարակվել է: (1993) -
TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
: Wilcock, G
Հրապարակվել է: (1990) -
PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
: Forsyth, D, և այլն
Հրապարակվել է: (1989) -
Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
: Ford, J, և այլն
Հրապարակվել է: (1993)